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The developmental brain gene NPAS3 stands out as a hot spot in human evo-
lution because it contains the largest number of human-specific, fast-evolving,
conserved, non-coding elements. In this paper we studied 2xHAR142, one of
these elements that is located in the fifth intron of NPAS3. Using transgenic
mice, we show that the mouse and chimp 2xHAR142 orthologues behave as
transcriptional enhancers driving expression of the reporter gene lacZ to a
similar NPAS3 expression subdomain in the mouse central nervous system.
Interestingly, the human 2xHAR142 orthologue drives lacZ expression to an
extended expression pattern in the nervous system. Thus, molecular evolution
of 2xHAR142 provides the first documented example of human-specific
heterotopy in the forebrain promoted by a transcriptional enhancer and
suggests that it may have contributed to assemble the unique properties of
the human brain.1. Introduction
A major goal of current evolutionary studies is the identification of the genetic
basis underlying the phenotypic differences that characterize Homo sapiens. In
the last 6 Myr of human lineage evolution, the genes that contributed to
peculiar human traits have probably acquired novel mutations in their coding
or regulatory sequence, leading to the origin of differential protein functional
domains or changes in their spatial or temporal expression, respectively. The
identification of the genetic bases underlying the evolution of H. sapiens has
been fuelled in the past decade by the availability of the human, several
other primate and mammalian genomes. By comparing sequences from ortho-
logue loci of several vertebrate genomes, including the human and chimpanzee,
it is possible to identify brain genes and genomic regions showing accelerated
evolution in the human lineage as candidates to reveal the molecular basis of
the particular configuration of the human brain. Several studies have identified
signatures of positive selection in the human lineage in the coding regions of
brain genes, suggesting that they might have played a role during recent
human evolution [1–6]. In addition, as part of genome-wide study to identify
non-protein-coding accelerated regions in the human genome, Pollard et al. [7]
identified the most dramatic human accelerated regions, HAR1, that is part of a
novel RNA gene (HAR1F) that is expressed in Cajal–Retzius neurons in the
developing human neocortex. Furthermore, the authors showed that HAR1F
is co-expressed with reelin, an extracellular matrix glycoprotein secreted by
Cajal–Retzius neurons that is of fundamental importance in specifying the
six-layer structure of the human cortex [7]. More recently, the analyses of dupli-
cations and deletions in the human lineage have led to the identification of
several genes related to brain function that underwent human-specific copy
number variation [8]. Among them, the gene SRGAP2 is noteworthy, as it
has at least one fixed human-specific partial duplication in the human
genome. SRGAP2 is a negative regulator of neuronal migration and promotes
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duplicated protein dimerizes with the full-length SRGAP2
protein, and thus it acts as a dominant partial inhibitor, pre-
sumably leading to neotenous changes, including increased
density of longer neurite spines [9,10].
Taking advantage of four recent independent genome-
wide studies performed to identify accelerated conserved
non-protein coding regions in the human genome [7,11–14]
that altogether detected approximately 1800 human acceler-
ated elements (HAEs), we have recently identified the gene
NPAS3 (neuronal PAS domain-containing protein 3) as an
exceptional case in human evolution as this gene contains the
largest cluster of 14 HAEs in the human genome [15]. NPAS3
encodes a transcription factor of the bHLH-PAS family [16]
and is mainly expressed in the developing central nervous
system of mice and humans as well as in the adult brain
[16,17]. Analysis of NPAS3-deficient mice showed that this
gene plays an important role during brain development and
the control of neurosignalling pathways [18,19]. In addition,
NPAS3 was identified as a candidate gene for schizophrenia
in family [20–23] and association studies [24,25].
Using an enhancer assay in transgenic zebrafish, we have
recently shown that 11 out of the 14 HAEs present in NPAS3
drive reporter gene expression to the developing central ner-
vous system, suggesting that the accelerated evolution of the
these regulatory sequences could have had an impact on the
expression of NPAS3 in humans [15].
To explore the possibility that the human-specific genetic
changes present in NPAS3 played a role in brain evolution,
we aim to study in more detail the expression of NPAS3-
HAE elements in a mammalian model. In this paper, we
studied 2xHAR142, one of the 14 NPAS3-HAEs, that is
located in the fifth intron of NPAS3. Using transgenic mice,
we show that the mouse and chimp 2xHAR142 orthologues
behave as transcriptional enhancers, driving expression of
the reporter gene lacZ to a similar NPAS3 expression sub-
domain in the mouse central nervous system. Interestingly,
the human 2xHAR142 orthologue drives lacZ expression to
an extended expression pattern in the nervous system. In
addition, we report here that 2xHAR142 enhancer contains
sequences derived from a short interspersed element (SINE)
retroposon of the MIR family. The high level of conservation
of the SINE-derived sequences suggests that the 2xHAR142
enhancer originated at least in part from an exaptation
event in the lineage leading to placental mammals.2. Results
(a) The accelerated non-coding region 2xHAR142
behaves as a developmental enhancer
We have recently performed a meta-analysis combining the
data of four recent independent genome-wide studies design-
ed to identify human genomic accelerated regions through
different comparisons and algorithms [7,11–14] that identified
1800 non-overlapping human accelerated elements (HAEs) in
the human genome [15]. In that work, we identified the tran-
scriptional units and genomic 1-megabase (1-Mb) intervals of
the entire human genome carrying the highest number of
HAEs. We found that the brain developmental transcription
factorNPAS3 contains the largest cluster of non-coding acceler-
ated regions in the human genome, with up to 14 elements thatare highly conserved in mammals, including primates, but
carry human-specific nucleotide substitutions [15]. Among
these 14 HAEs, we decided to study in detail the function
and evolution of the region 2xHAR142 that comprises
165 bp in the human genome (chr14: 33 118 402–33 118 566;
figure 1). In order to study the function of the 2xHAR142
accelerated element, we cloned 502 bp containing the Phast-
Cons conserved region containing the human 2xHAR142
(2xHAR142-Hs) sequence cloned upstream of the HSP68mini-
mal promoter fused to the reporter gene lacZ and generated
transgenic mouse lines (figure 1). We generated five indepen-
dent transgenic mouse lines (see electronic supplementary
material, figure S1) and studied the expression pattern of the
reporter gene lacZ at three mouse-developmental stages.
Although we observed line-to-line variation, most probably
owing tovariable numbers and position of transgene insertions
in the genome (see electronic supplementary material, figure
S1), we observed that the 2xHAR142-Hs transgene behaves
as a consistent developmental enhancer driving the expression
of lacZ to the central nervous system, including the brain and
the spinal cord at the three stages analysed (figure 1; electronic
supplementary material, figure S1). At E10.5 and E12.5, we
observed expression of lacZ in regions of the hindbrain, the
midbrain and the forebrain. At E12.5 and E14.5 in the forebrain,
the expression is mainly located at the developing cortex
(figure 1e,f ), in the hippocampal neuroepithelium bed nucleus
of the stria terminalis, ventral thalamus and the hypothalamus
(figure 1e,f ). In the midbrain, we observed expression at the
tegmentum and the cerebral peduncles. In the hindbrain, we
observed extensive expression, including the cerebellar neuro-
epithelium, the pontine reticular nucleus, the fasciculus, etc.
Outside the nervous system, we observed lacZ expression in
the limb buds, the eyes, developing inner ear, vertebral body
primordia, etc. (figure 1; electronic supplementary material,
figure S1).
To determine whether the accelerated evolution led
to changes in the expression pattern of this developmental
enhancer, we generated and analysed transgenic mice carrying
the 2xHAR142 mouse (2xHAR142-Mm) and chimpanzee
(2xHAR142-Pt) orthologues. We found that three independent
lines of 2xHAR142-Mmmice expressed consistently the report-
er gene lacZ at a reduced expression domain that includes
a subdomain of the 2xHAR142-Hs expression pattern. We
observed expression in the spinal cord, in the hindbrain and
low expression in the midbrain. At the forebrain, we observed
expression in the preoptic area, but notably these transgenic
mice did not show any expression in the developing cortex
(figure 2; electronic supplementary material, figure S1).
To address whether the differences in expressionwere only
driven by the human accelerated region and not present in
other primates, we generated three transgenic mouse lines car-
rying the chimpanzee 2xHAR142 sequence (2xHAR142-Pt).
We analysed the expression pattern of the reporter gene
driven by the 2xHAR142-Pt sequence and observed that the
expression of lacZ in the developing nervous system is more
similar to the one driven by the 2xHAR142-Mm than to the
2xHAR142-Hs (figure 2; electronic supplementary material,
figure S1). In fact, expression domains include the spinal cord
and the hindbrain, and low expression was observed in the
midbrain. In the forebrain, we only observed expression in
the preoptic area, whereaswe did not observe expression in the
developing cortex driven by the 2xHAR142-Pt sequence,
in high contrast to the strong expression in this region driven
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Figure 1. Location of exapted repeats and HAEs at the NPAS3 locus in the human genome. (a) Location of the NPAS3 gene in NCBI build 36.1 of the human
genome assembly showing exapted elements [26,27] and HAEs [15]. (b) Conservation of the 2xHAR142 sequence of the region according to the UCSC Genome
Browser (www.genome.ucsc.edu). (c) Scheme of the transgene containing the 2xHAR142 sequence ligated to the mouse minimal Hsp68 promoter followed by the
Escherichia coli lacZ reporter gene. Below, expression pattern of lacZ driven by 2xHAR142-Hs at E10.5 (d ), E12.5 (e) and E14.5 ( f ) whole mount embryos and
histologically selected sections of a representative 2xHAR142-Hs transgenic mouse line. Forebrain (fb); midbrain (mb); hindbrain (hb); spinal cord (sc); lateral
ventricle (lv); preoptic area (pa); olfactory bulb (ob); ganglionic eminence (ge); thalamus (th); hypothalamus (hy); hippocampus (hi).
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tary material, figure S1). In addition, we noted that the
2xHAR142-Pt sequence drives expression to the eyes, limb
buds, developing inner ear, vertebral body primordia, etc.
(see electronic supplementary material, figure S1). The
expression in the limb buds and vertebral body primordia
seems to be a characteristic of the two primate enhancers but
is absent in the mouse enhancer. More work will be necessary
to assess whether these expression domains were gained in
the primate lineage or lost in the mouse lineage. We observed
that the 2xHAR142-Hs sequence shows 98% identity with the
chimpanzee sequence (seven human-specific substitutions on
the PhastCons region; electronic supplementary material,
figure S3) and 85% identity with the mouse sequence harbour-
ing 37 substitutions across the PhastCons region. These data
suggest that the changes acquired after the split of the humanand chimpanzee lineages could be responsible for the acqui-
sition of new expression territories driven by the human
sequence in the developing nervous system.(b) The 2xHAR142 sequence drives the expression of
the lacZ reporter gene to an overlapping expression
domain of the gene NPAS3
In order to determine whether the enhancer sequence
2xHAR142 behaves as an NPAS3 regulatory sequence, we
aimed to compare the expression of the 2xHAR142 sequence
with the NPAS3 gene expression pattern. The expression pat-
tern of the gene NPAS3 during mouse central nervous system
development has only been partially described [16], conse-
quently we also aimed to analyse in detail expression
(a) 2xHAR142-Hs
2xHAR142-Pt
2xHAR142-Mm
(b)
(c)
Figure 2. Comparative expression analysis of human, chimpanzee and mouse
2xHAR142 orthologue sequences in transgenic mice. Whole mount and selected
sagital cryostat sections of F1 transgenic mouse embryos showing lacZ expression
patterns obtained with each transgene in a (a) human, (b) chimpanzee and
(c) mouse representative transgenic line at E12.5.
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difficulty in getting antibodies to detect NPAS3 during mouse
development, we studied the expression pattern of NPAS3
using in situ hybridization (ISH). We performed ISH studies
at the three developmental stages thatwe had analysed in trans-
genic mice. In addition, to study the cellular types where
NPAS3 is expressed duringmouse development, we performed
fluorescent ISH studies to detect NPAS3 in combination with
different cellular markers in the nervous system.
At E10.5, we observed that the NPAS3 is expressed all
across the neuroepithelium in the hindbrain, midbrain and
forebrain (figure 3a– j). Expression of NPAS3 greatly overlaps
with cells expressing the undifferentiated neural precursor
cell (NPC) marker SOX2. We observed numerous cells
expressing both SOX2 and NPAS3 (figure 3b–e and g– j ).
On the other hand, we detected less density of cells expres-
sing NPAS3 in the external layers of the neuroepithelium
where cells express the early neuronal markers DCX and b
III-tubulin or TUJ1 (figure 3a,f ).
At E12.5, we observed expression of NPAS3 in the develop-
ing central nervous system as well as other areas including the
inner ear, the eye and the olfactory epithelium (not shown). In
the central nervous system, we detected expression in the fore-
brain, midbrain, hindbrain and spinal cord (figure 3). In the
hindbrain, NPAS3 is expressed all across the neuroepithelium,
and especially high expression is observed in the ventricular
zone. This area close to the fourth ventricle is populated
by SOX2-expressing cells and we observed that a very high
proportion of these cells also express NPAS3 (figure 3u–y).
Additionally, numerous NPAS3-expressing cells away from the
ventricle also expressed DCX (figure 3p–t) and fewer expressed
TUJ1 (figure 3aa–ee). In the forebrain, at the developing cortex,
we observed a similar pattern of high density of NPAS3-SOX2-
expressing cells in the ventricular zone (not shown) and cells in
the cortical plate expressing NPAS3 and TUJ1.There are technical difficulties in simultaneously detecting
NPAS3 and b-galactosidase. Thus, we used the detection of
b-galactosidase in combination with the cellular markers that
we had used in conjunction with NPAS3-ISH to infer whether
the expression of the reporter gene lacZ and the NPAS3 gene
overlap. We observed that the expression of b-galactosidase
driven by the 2xHAR142-Pt and 2xHAR142-Mm sequence
co-localizes mainly with DCX- and TUJ1-expressing cells,
whereas minimum overlap was observed in SOX2-expressing
cells in the hindbrain and spinal cord (figure 4; electronic
supplementary material, figure S2).
However, we had observed that the expression pattern of
NPAS3 at E12.5 includes the complete neuroepithelium at the
spinal cord and the hindbrain (figures 3 and 4e,f,i,j,m,n,dd),
and NPAS3 is highly expressed in SOX2-positive cells.
Altogether, our results indicate that the enhancer sequences
2xHAR142-Pt and 2xHAR142-Mm drive the expression of
the reporter gene lacZ to a subdomain of theNPAS3 expression
pattern and suggest that this enhancer participates in the
expression regulation of NPAS3.
(c) The accelerated non-coding region 2xHAR142
contains sequences derived from an MIR retroposon
We observed that 30 nucleotides of the 2xHAR142 region
overlap with the exapted element exap2775 as described by
Lowe et al. [26] (figure 1; electronic supplementary material,
figure S3). The term ‘exaptation’ was suggested in 1992 by Bro-
sius & Gould [28] to name the examples of transposable
elements (TEs) acquiring novel functions in the genome. Since
then, many examples of TE exaptation as putative or demon-
strated transcriptional regulatory regions have accumulated
(for a review, see [29]); however, only in a few cases it was pos-
sible to demonstrate functionally that regulatory innovation
was mediated by the TE exaptation event [29]. The exap2775
region comprises 73 bp that are included in the PhastCons
conserved sequence (280 bp) that contains the accelerated
region 2xHAR142 (figure 1; electronic supplementary material,
figure S3). As exap2775 does not overlap with a Repeat Masker
annotated mobile element, we used several strategies in order to
find out the identity of the mobile element present in the con-
served region. In addition, we aimed to determine the time at
which this element originated in the history of vertebrates.
In order to determine the type of mobile element from
which exap2775 originated, we searched orthologue sequences
of exap2775 in the human genome using BLAT. We found that
significant hits of exap2775 in the human genomewere located
in annotated SINE retroposons of the MIR family. MIRs or
mammalian-wide interspersed repeats are t-RNA-derived
SINEs [30] from the CORE-SINE superfamily [31]. To identify
the subfamily of MIRs from which the exap2775 element origi-
nated, we performed exhaustive sequence comparisons using
BLAST among exap2775 and all MIR sequences present in the
RepBase database. We found that the region of highest simi-
larity correspond to the CORE region of MIRs. In addition,
we found the highest similarity to members of the MIRb and
MIRc subfamilies (see electronic supplementary material,
figure S3). To confirm this finding, we also searched the
exap2775 element using the P-clouds tool designed to detect
TEs using a different strategy to that used by Repeat Masker
[32]. We found that exap2775 overlaps with a P-clouds MIR
annotated element in the human genome (see electronic
supplementary material, figure S3).
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Figure 3. NPAS3 expression in the developing mouse brain. The expression of NPAS3 is shown through ISH in combination with immunohistochemical detection of
the early neuronal markers DCX and b III-tubulin (TUJ1) and the undifferentiated NPC marker SOX2 in cryostat sections of E10.5 and E12.5 mouse embryos.
Expression of NPAS3 at E10.5 is shown in the hindbrain (a–e) and the forebrain ( f– j) in combination with DCX (a,f ) and SOX2 (b–e and g– j). At E12.5
expression is shown in the spinal cord (k–o), the hindbrain ( p–y and aa–ee) and the forebrain ( ff– jj). In the spinal cord, NPAS3 is shown in combination
with SOX2 (k) and TUJ1 at low (l ) and high magnification (m–o). In the hindbrain, expression is shown in combination with DCX ( p–t), SOX2 (u–y) and
TUJ1 (aa–ee). In the forebrain, the expression is shown in combination with TUJ1 at low ( ff,gg) and high magnification (hh– jj).
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mammals and not present in non-placental mammals and
other vertebrates (figure 1; electronic supplementary material,figure S3). In order to trace the origin of this sequence, we
performed BLAST searches using the exap2775 region as
query against all sequenced non-placental mammal vertebrate
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Figure 4. b-Galactosidase expression pattern at E12.5 in different cellular types in the developing brain. (a) Schematic of an E12.5 whole embryo where a red line
indicates the approximate location of the histological section located below. (b) Low-resolution image of a histological section of a transgenic mice expressing b-galac-
tosidase under the control of the 2XHAR142-Pt sequence in the hindbrain and spinal cord. White boxes over the image indicate approximate location of the high-resolution
images shown on the right. High-resolution confocal photographs at the right show the expression pattern of the reporter gene lacZ protein product b-galactosidase
(bgal) at different levels of the spinal cord (c,d,g,h,k,l,o,p) and the hindbrain (s–z and aa–bb). The expression of b-galactosidase is shown in combination with the
expression of the early neuronal markers DCX andb III-tubulin (TUJ1) and the undifferentiated NPC marker SOX2 in the developing central nervous system. The expression
of NPAS3 in combination with the same cellular type markers is shown for some cases at approximate similar levels in the spinal cord (e,f,i,j,m,n) and the hindbrain (cc,dd).
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showed that all significant hits were located in MIR-derived
sequences, although none of them was located in the NPAS3locus. We observed similar results searching the platypus
(Ornitorhynchus anatinus) genome where all significant hits
were found in CORE-SINEs-derived sequences of the type
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the chicken genome (Gallus gallus) resulted in a few low-score
hits that where not located in identified mobile elements.
Re-BLAST of the identified sequences of the chicken genome
indicated that they were not originated by mobile elements
but unique sequences in the genome. Similarly, the highest scor-
ing hits in the zebrafish genome where not in mobile-elements-
derived sequences. Altogether, our analyses indicated that the
mobile element from which the sequence exap2775 originated,
was derived from a SINE retroposon, most probably of the
MIR family. In addition, our data showed that although SINE
elements of the MIR family are present in non-placental mam-
malian species, the exaptation of the MIR element from which
exap2775 originated occurred in the lineage leading to placental
mammals. Even though full-lengthMIR retroposons are around
250 bp, only a smaller portion of the consensus element was
recognized as the repeat derived element exap2775 (73 bp). In
order to test whether additional signatures of the original full-
length MIR retroposon are still recognizable in the enhancer
sequence tested, we have aligned mammalian orthologues of
the sequence containing the 2xHAR142 region with full-length
MIR consensus sequences from RepBase (MIR, MIRb and
MIRc) and particular MIR instances from the genome that
were retrieved using exap2775 as a query (see electronic sup-
plementary material, figure S3). We found that additional
signatures of the original MIR are still recognizable outside the
exap2775 region, suggesting that a full-length MIR element
inserted in the region in the lineage leading to placental mam-
mals and accumulated mutations before it started to be under
purifying selection (see electronic supplementary material,
figure S3). Although acomplete proof of the functional relevance
of the MIR-derived sequences would require further deletional
studies, thehigh level of conservation (see electronic supplemen-
tarymaterial, figure S3) suggest that theMIR-derived sequences
were probably exapted into cis-regulatory sequences and main-
tained under purifying selection all throughout the evolution of
placental mammals.(d) Acceleration and exaptation
Afterwards, we aimed to analyse whether exap2775 was the
only non-coding conserved sequence derived from a mobile
element in the NPAS3 gene genomic region. We found that
10 exapted repeats had already been identified by Lowe
et al. [26] in the NPAS3 region and only one of them
(exap2775) overlaps an HAE (figure 1). Our genome-wide
analysis found that from the 1800 HAEs only 31 overlap
exapted repeats from the 10 402 described by Lowe et al.
[26] covering 8743 bases of the human genome. Twenty
eight of the 31 HAEs originated from exapted mobile
elements correspond to HACNS and three to 2xHARs.
A second database of exapted repeat elements has been
more recently described [12,27] containing a total of 284 857
regions. Using this database that we call exapted repeats
2011, we mapped 138 exapted repeats in the NPAS3 region,
ranging from 5 to 238 bp in length. Three of these newly
described elements overlapped with the previous database
(exap2772 and exap2778). In addition, we found no overlap
between exapted repeats 2011 and HAEs in the NPAS3 geno-
mic region, whereas at the whole-genome level, we found
that 133 exapted repeats 2011 overlap with HAEs. To analyse
whether NPAS3 shows an exceptional amount of exapted
element in the genome,we analysed the distribution of exaptedrepeats by gene. For that purpose, we obtained a unique non-
overlapping database of exapted elements from the 2007 and
the 2011 databases and intersected this with a database of
gene transcriptional units, defined as the genome interval
delimited by the largest reported RefSeq transcript for each
gene. This analysis showed that theNPAS3 region accumulates
a total of 145 exapted repeats (figure 1; electronic supple-
mentary material, table S1). We observed that even though
some exapted repeats were reported as individual exaptation
events, they are clustered very closely and overlap the same
mobile element, suggesting that they constitute a unique exap-
tation event (see electronic supplementary material, table S1).
We discovered that from a total of 19 897 annotated human
RefSeq genes (human genome assembly 2006; NCBI36/
hg18), 10 754 carry at least one exapted repeat in their transcrip-
tional unit. We found that 10 707 genes contained between 1
and 144 exapted repeats, whereas only 39 genes display more
than 145 exapted repeats. Surprisingly, we observed that
there are several genes harbouring more than 300 exapted
repeats in their transcriptional unit (see electronic supplemen-
tary material, table S2). We found that, as expected, genes with
long transcriptional units accumulate large amounts of exapted
elements (see electronic supplementary material, table S2). In
order to take into account the gene-length factor, we also ana-
lysed the accumulation of exapted element by fixed length
units of 1 Mb of the human genome. We found that two out
of three of the 1-Mb genomic regions that accumulate the lar-
gest amounts of exapted elements (more than 400) are the
ones that contain the top harbouring exapted element genes
PTPRT and CSMD2 (see electronic supplementary material,
table S2). More work will be necessary to clarify why exapted
elements accumulate in particular genes or genomic regions.
Subsequently, to characterize in more detail and to date the
exaptation events at theNPAS3 region, we analysed the type of
mobile element fromwhich the exapted regions originated.We
found that 137 elements overlapped Repeat Masker annota-
tions (REPEAT MASKER v. 3.2.7), facilitating its identification.
Out of these 137 elements, 50 were identified as SINEs, 70 as
long interspersed elements (LINEs) and 10 as DNA transpo-
son-derived elements (see electronic supplementary material,
table S1). Our data indicate that the types of mobile element
from which the exapted regions originated in the NPAS3
region do not differ from the general trend that has been
reported at the genome level [26,27]. Additionally, using
BLAST searches, we identified the mobile elements from
which the exapted repeats originated that do not overlap
with Repeat Masker annotations in the genome (see electronic
supplementary material, table S1).
Thereafter, to date all the exaptation events at the NPAS3
locus, we analysed the conservation of the exapted elements
using sequence alignments of all available vertebrate genomes
for each element. The majority of the NPAS3 exapted elements
seem to have been co-opted in the lineage leading to placental
mammals (85; 61.6%). In addition, 28.26% and 10.15% were
exapted in the lineage leading to mammals and vertebrates,
respectively (see electronic supplementary material, table S1).3. Discussion
In this paper, we show that the human accelerated region
2xHAR142 is a mammalian novelty that seems to have origi-
nated, at least partially, from the exaptation of a SINE
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mammals. In addition, we show that the 2xHAR142 sequence
is not the only conserved non-coding sequence in the NPAS3
locus containing mobile element-derived sequences, because
the transcriptional unit of this gene accumulates 145 exapted
elements as previously defined [12,26,27]. Moreover, we
show that of the 19 897 annotated human RefSeq genes in
the human genome, 10 754 carry at least one exapted repeat.
We found that 10 707 genes contained between 1 and 144
exapted repeats, whereas only 47 genes display more than
145 exapted repeats, indicating that the locus containing
NPAS3 underwent extensive co-option of mobile elements
into non-coding conserved sequences throughout the evo-
lution of vertebrates. Our findings add another example
to the growing list of functionally characterized cases of
transcriptional enhancers containing mobile-element-derived
sequences throughout the evolution of living forms [33–38].
In this work, we also demonstrated that 2xHAR142 is an
enhancer that drives the expression of the reporter gene lacZ
to a subdomain of the NPAS3 expression pattern. We found
that the accelerated evolution process that this sequence
underwent in the human lineage has probably led to a shift
in its expression pattern. In fact, we show here that transgenic
mice carrying the human version of 2xHAR142 display an
extended expression pattern compared with the chimpanzee
or the mouse orthologues.
It has been hypothesized that distinctive human traits
such as the use of a complex language, long-term planning
and exceptional learning capacities are the result of molecular
changes that led to modifications in the developmental pro-
gramme of our brain that occurred during the past 6 Myr of
human lineage evolution.
Almost 40 years ago, King & Wilson [39], on the basis of
the Ohno hypothesis about the evolution of regulatory sys-
tems [40], proposed the idea that evolution of non-coding
regulatory sequences played a major role in shaping the
unique features of the human brain. However, a proof of con-
cept of this idea is still pending. As protein-coding regions
account for only one-third of all conserved sequences in the
human genome and several studies performed in other
species showed that lineage-specific evolution of regulatory
sequences appeared to have driven phenotypic changes (see
for reviews [41,42]), detection of human-specific accelerated
conserved non-coding regions provides the raw material to
identify those human-specific molecular changes that led to
phenotypic evolution.
Recently, four independent genome-wide studieswere per-
formed to identify accelerated conserved non-protein coding
regions in the human genome [7,11–14] that together detected
approximately 1800 genomic human fast-evolving regions.
Although these studies searched for conserved genomic
regions with accelerated substitution rates specific for the
human branch, each of them yielded partially overlapping
output sequences, probably because they used different types
and numbers of compared species and different algorithms
to assess acceleration. As gene loci densely populated with
HAEs are more likely to have contributed to human-specific
novelties, we have recently performed a meta-analysis of
these four public databases to identify clusters of human geno-
mic accelerated elements. Our study revealed that most
transcriptional units and 1 Mb intervals carry none, 1, 2 or 3
HAEs, and only very limited cases showed a concentration
of HAEs greater than seven [15].It has been more difficult to assess the functional impact
of the evolutionary process than to identify signatures of
accelerated evolution and positive selection in the human
lineage. It has been shown that the most dramatic human
accelerated region, HAR1, is part of a novel RNA gene
(HAR1F) that is expressed in Cajal–Retzius neurons in the
developing human neocortex from seven to 19 gestational
weeks, a crucial period for cortical neuron specification and
migration. HAR1F is co-expressed with reelin, a product of
Cajal–Retzius neurons that is of fundamental importance in
specifying the six-layer structure of the human cortex [7].
However, the HAR1F expression pattern in rhesus macaque
is very similar to that observed in the human developing
brain at comparable gestation stages. These results indicate
that despite extensive sequence changes, the expression pat-
tern of HAR1F in the developing cortex has been highly
conserved since the divergence of hominoids and Old
World monkeys around 25 Myr ago [7].
In addition, it has been reported that the conserved non-
coding sequence HACNS1 that evolved extremely rapidly in
humans acts as an enhancer of gene expression in transgenic
mice. Moreover, it has been shown that the HACNS1 human
orthologue gained a strong gene expression domain in the
limbs compared with the chimpanzee and rhesus macaque
orthologue elements [43]. However, the potential impact of
human-specific changes in the expression of neighbour genes
(CENTG2 and GBX2) and on limb development remains to
be explored [43].
It has been shown that two amino acid substitutions in the
transcription factor FOXP2 have been positively selected
during human evolution [1,44]. In order to assess the func-
tional impact of these evolutionary changes, these two amino
acids were replaced in the mouse orthologue locus in order
to create ‘humanized’ FOXP2 mice [45]. Extensive phenotypic
analysis of these mice indicated that they have qualitatively
different ultrasonic vocalizations, decreased exploratory be-
haviour and decreased dopamine concentrations in the brain,
suggesting that the humanized Foxp2 allele affects basal
ganglia. As humans who carry one non-functional FOXP2
allele show some alterations in the basal ganglia, the authors
speculate that alterations in cortico-basal ganglia circuits as a
result of the evolution of FOXP2 might have been important
for the evolution of speech and language in humans. However,
more research will be necessary to make a stronger link
between FOXP2 and the evolution of speech in humans.
More recent work has identified the locus AUTS2 which
contains the most significantly accelerated genomic region
differentiating humans from Neanderthals. Using a combin-
ation of enhancer assays in transgenic zebrafish and mice,
the authors characterized regulatory regions responsible for
the expression of the gene in the brain as well as brain enhan-
cers that overlap an autism spectrum disorder-associated
deletion and brain enhancers that reside in regions implicated
in human evolution [46].
We have recently shown that in addition to 2xHAR142,
the gene NPAS3 accumulates 14 HAEs in its transcriptional
unit, indicating that this gene is a hot spot in human evo-
lution [15]. Using a transgenic zebrafish enhancer assay, we
have shown that 11 out of the 14 HAEs present in NPAS3
drive reporter gene expression to the developing central ner-
vous system, suggesting that the accelerated evolution of
these regulatory sequences could have had an impact on
the expression of NPAS3 in humans [15].
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transcriptional enhancer during mouse development, driving
the expression of the reporter gene lacZ to a subdomain of
the NPAS3 expression pattern. These results suggest that
2xHAR142 participates in the regulation of NPAS3 expression.
In addition, our data also suggest that the overall expression of
NPAS3 is probably controlled byother enhancer sequences.We
have already shown that at least 11 NPAS3-HAEs behave as
transcriptional enhancers in transgenic zebrafish [15]. More-
over, the large locus that the gene NPAS3 occupies in the
genome means that it contains additional non-coding con-
served sequences which could also participate in the
regulation of its expression andwhich have not been character-
ized so far. Together these data suggest that the control of
expression of the gene NPAS3 is very complex and further
work needs to be done in order to understand it completely.
So far, we have shown two cases ofNPAS3-HAEs where accel-
erated evolution of non-coding regulatory sequences led to
functional changes [15]. These data strongly suggest that the
dramatic accelerated evolution that this gene underwent affect-
ing 14 regulatory regions could have resulted in significant
modifications of NPAS3 expression in humans.
Finally, the gain of function displayed by the 2xHAR142
human enhancer shown here provides the first documented
example of human-specific heterotopy in the forebrain pro-
moted by a transcriptional enhancer and suggests that it
may have contributed to shape the expression of NPAS3
and the unique properties of the human brain.4. Material and methods
(a) Sequences and databases
In order to obtain a unique non-overlapping database of exapted
repeats, we intersect in the Table Browser of the UCSC Genome
Browser (www.genome.ucsc.edu) the exapted repeats track [26]
and a custom track of exapted repeats 2011 [12,27] obtained from
the 29 mammals project website (http://www.broadinstitute.
org/scientific-community/science/projects/mammals-models/
29-mammals-project-supplementary-info). To obtain the numberof
exapted repeats for a gene transcriptional unit, we used the non-
overlapping exapted repeats databasewith a database of gene tran-
scriptional units, defined as the genome interval delimited by the
largest reported RefSeq transcript for each gene or four datasets of
1 Mb-length genomic intervals that overlapped every 250 kb,
using Galaxy tools (http://main.g2.bx.psu.edu/). All the analyses
were performed in the human NCBI36/hg18 genome assembly.
Identification of mobile elements was performed using the REPEAT
MASKER track v. 3.2.7, and the repeat masking search was perform-
ed in the Repeat Masker web site (http://www.repeatmasker.org).
We downloaded mobile element consensus sequences from
Repbase (http://www.girinst.org/repbase/) and performed
BLAST searches locally and in the BLAST web site (http://blast.
ncbi.nlm.nih.gov). We also analysed the exap2775 sequence using
P-clouds [32]. We used the MIR-specific custom tracks annotated
in the human genome (available from [32]).
(b) Transgenes and transgenic mice production
Sequences 2xHAR142-Hs and 2xHAR142-Pt were amplified by
proofreading PCR from human and chimpanzee genomic samples
(chimpanzee samples were kindly donated by Adrian Sestelo).
The resulting PCR fragments were directionally cloned into
the vector pENTR/D-TOPO (Invitrogen, Carlsbad, CA, USA)
through the CCAC sites added to the forward primer. Sequence
identities were confirmed by sequencing. Fragments cloned inthe pENTR/D-TOPO vector were transferred by site-specific
recombination using the LR Clonase Enzyme mix (Invitrogen) to
the pGW-Hsp68-lacZ vector which had previously been engin-
eered to introduce recombination recognition sites (kindly
donated by Dr Marcelo Nobrega, see reference [47]). Transgene
2xHAR142-Mm was amplified by proofreading PCR from a mouse
genomic sample. The resulting PCR fragment was directionally
cloned into the vector pZErO-2 (Invitrogen). Sequence identity was
confirmed by sequencing. The plasmid pZErO-2/2xHAR142-Mm
was digested with SalI and XmaI, and a fragment was subcloned
into pHsp68-lacZ. Primer pairs used to amplify TG-2xHAR142-
Hs and TG-2xHAR142-Pt were TG-2xHAR142-Hs–F: 50-caccCA
ACCAACACCAGCTAGAAAG-30, TG-2xHAR142-Pt: 50-caccGCA
ACCAACACCAGCTTGAAAG-30 and TG-2xHAR142-Hs/Pt-R:
50-CAAGAATTCAATTAAATGCACAACTGAACAGG-30. Primer
pairs used to amplify TG-2xHAR142-Mm were TG-2xHAR142-
Mm-F: 50-ACGTCGACCTTTTGAGCCAGGTCCACTC-30 and
TG-2xHAR142-Mm-R: 50-ACCCCGGGACGAGGGGGAAAAGA
TCACT-30. Prior to microinjection, each pGW-Hsp68-lacZ-Hs/Pt
vector was digested with SalI and pHsp68-LacZ-Mm was digested
with SalI and Not I to liberate the transgenes. Then transgenes
were eluted from an agarose gel using QIAquick Gel Extraction
Kit (Qiagen, Valencia, CA, USA) and purified with Elutip-D
columns (Schleicher & Schuell, Keene, NH, USA). After precipitat-
ing with NaOAc (3 M, pH 5.2) and ethanol, the DNAwas washed
with ethanol 70% and resuspended with microinjection buffer
(filter sterile Tris–HCl 5mM, pH 7.4; EDTA 0.1 mM). Transgenic
mice were generated by pronuclear microinjection of B6CBF2 or
FVB zygotes as described previously [34,36]. Microinjected
zygotes were transferred to the oviduct of B6CBF2 pseudo-preg-
nant females. Transgenic pups were identified by PCR on ear
punches genomic DNA with a combination of a forward trans-
gene-specific primers and a reverse lacZ-specific primer. Primer
pairs used were TG2xHAR142-Mm_F: 50-TTCGGAATAAATGG
GCTCCT-30, TG2xHAR142-Hs/Pt_HSP_GW_F: 50- TCCCTGTTC
AGTTGTGCATT-30 and LacZ_R1: 50-AAGGGGGATGTGCTG
CAAGGCG-30. Mice were kept in a ventilated rack (Thoren
Caging Systems, Hazleton, PA, USA) under a 12 L : 12 D cycle and
20–228C room temperature (RT).(c) X-Gal histochemistry
Transgene expression was determined in F1 mouse embryos of
all independently generated pedigrees. Timed pregnant dams
were obtained by mating B6CBF1 females with F0 or F1 trans-
genic males from all transgenic pedigrees. After killing the
pregnant dam at defined post coitum days (dpc), embryos
were removed immediately, washed with 1 phosphate-buffered
saline (PBS; 0.1 M, pH 7.4) and fixed with 4% paraformaldehyde
in 1 PBS during 30 min (for E9.5 to E12.5 dpc embryos) and 1 h
(E14.5 dpc embryos). b-Galactosidase activity was determined in
whole-mount embryos with 1 mg ml21 of 5-bromo-4-chloro-3-
indolyl-b-D-glucuronic acid (X-Gal) in 1 PBS pH 7.3 containing
2.12 mg ml21 of potassium ferrocyanide, 1.64 mg ml21 of potas-
sium ferricyanide, 2 mMMgCl2, 0.01% sodium deoxycholate and
0.02% NP-40 overnight at 378C. To analyse b-galactosidase
activity in sagittal sections, whole-mount embryos were first
stained with X-Gal as described above. Then the specimens
were rinsed in 1 PBS overnight at 48C, cryoprotected in 10%
sucrose solution in 1 PBS and embedded in 10% gelatin with
10% sucrose in the same buffer. The blocks were frozen for
1 min in isopentane cooled to 2558C in dry ice and were
stored at 2808C. Serial 20 mm thick (10.5 dpc embryos) and
30 mm thick (12.5 and 14.5 dpc embryos) sections were cut in a
cryostat (Leica CM1850, Germany), collected on Super-Frost
Plus slides (Fisher Scientific, USA) and stored at 2808C until
use. On the day of use, sections were air dried at RT for 2 h,
post fixed with cold 4% paraformaldehyde in 1 PBS for 10 min
rstb.royalsocietypublishing.org
PhilTransR
SocB
368:20130019
10
 on January 28, 2017http://rstb.royalsocietypublishing.org/Downloaded from and then washed with 1 PBS twice for 10 min each. X-Gal re-
staining was performed at 378C overnight. After X-Gal staining
was completed, slides were washed three times for 5 min each
in 1 PBS, once in water for 5 min and then incubated for 1 h
in filtered 0.5% eosin (Sigma-Aldrich, USA) in a glacial acetic
acid solution (0.16%, pH 6.0), then washed in distilled water for
15 s and dehydrated through ethanol series. Finally, slides were
placed in xylene for 1 min and slip-covered using DPX (Fluka,
Germany). Images were acquired using a Leica MZFLIII micro-
scope coupled to a Leica DFC320 camera.
(d) In situ hybridization
The embryos were fixed by immersion in 4% paraformaldehyde
solution in 1 PBS at 48C overnight. The specimens were rinsed
in 1 PBS at 48C overnight, cryoprotected in 10% sucrose solution
in 1 PBS and embedded in 10% gelatin with 10% sucrose in the
same buffer. The blocks were frozen as described above. Serial
16 mm thick (10.5 dpc embryos) or 20mm thick (12.5 and 14.5 dpc
embryos) sagittal sections were cut in a cryostat (Leica CM1850,
Germany), collected as parallel series on Super-Frost Plus slides
(Fisher Scientific) and stored at –808C until use. A 460 bp NPAS3
probe previously characterized [16] was amplified by proofreading
PCR from mouse adult brain cDNA samples using the following
primer pair: NPAS3probe1_F: 50-CGAAT AACTGCCCAGCATC-
30 and NPAS3probe1_R: 50TTTTCCTTCT TGATTTAGTGCAAA
30. The resulting PCR fragment was cloned into pGEM_Teasy (Pro-
mega, Madison, WI, USA) and sequenced to confirm identity.
Plasmids containing the probewere linearized using SpeI and tran-
scribed using T7 RNA polymerase (Roche, Penzberg, Germany) to
generate digoxigenin-labelledNPAS3 antisense riboprobe. We per-
formed ISH on cryosections as previously described [48]. Briefly,
the thawed sections were postfixed with 4% paraformaldehyde in
1 PBS for 10 min and then washed three times with 1 PBS for
10 min. They were subsequently permeabilized in 1% Triton
X-100 in 1 PBS for 30 min. Thereafter, prehybridization occurred
at RT for 4 h in a solution containing 50% formamide, 10% dextran
sulfate, 5Denhardt’s solution and 250 mg ml21 t-RNA.Hybridiz-
ation was performed with 200–300 ng ml21 of the probe in the
same hybridization solution at 728C for 16 h. After hybridization,
the sections were washed with 0.2 sodium-saline citrate buffer
(SSC; 0.3 M sodium chloride, 30 mM trisodium citrate, pH 7) at
728C for 2 h, thereafter 15 min with 0.2 SSC plus 2% H2O2 and
then twice with a solution containing 100 mM NaCl, 0.1% Triton
X-100 and 100 mM Tris–HCl (pH 7.5). After blocking with 10%
normal donkey serum (NDS) in the same solution for 2 h, the sec-
tions were incubated overnight with horseradish peroxidase-
conjugated, anti-digoxigenin Fab fragments (Roche, Germany; 1 :
500). The sections were washed twice with the same buffer and
then incubated in 1/100 cyanine-3 tyramide reagent in 1 Plus
Amplification Diluent (PerkinElmer Life and Analytical Sciences,
Shelton, CT, USA). The tyramide signal amplification reactionwas allowed to proceed for 30 min protected from light. Thereafter,
the slides were washed with 1 PBS overnight.
(e) Immunohistochemistry
The embryos were fixed by immersion in 4% paraformaldehyde
solution in 1 PBS at 48C for 4 h. The specimens were cryopro-
tected and frozen as described above. Serial 16 mm thick (10.5
dpc embryos) or 20 mm thick (12.5 and 14.5 dpc embryos) sagittal
sections were cut in a cryostat (Leica CM1850, Germany), col-
lected as parallel series on Super-Frost Plus slides (Fisher
Scientific) and stored at –808C until use. Sections were air
dried at RT for 1 h and incubated for 2 h at RT in blocking sol-
ution (10% NDS, 0.1% Triton X-100, 1 PBS) followed by
incubation with a mix of primary antibodies diluted in blocking
solution overnight at 48C. Sections were washed three times in
1 PBS and then incubated sequentially for 1 h at RT with
each secondary antibody. Primary antibodies used were rabbit
polyclonal anti-b-galactosidase (1/1000; Cappel, MP Biomedical,
Santa Ana, CA, USA), goat polyclonal anti-SOX-2 (1/100; Santa
Cruz Biotechnology, Santa Cruz, CA, USA), goat polyclonal anti-
Doublecortin (1/100; Santa Cruz Biotechnology) and mouse
monoclonal anti-Neuronal Class III b-Tubulin (1/100; Covance,
Princeton, NJ, USA). Secondary antibodies used were donkey
anti-rabbit-AF555 (1/1000; Molecular Probes, Invitrogen),
donkey anti-goat-AF488 (1/1000; Molecular Probes, Invitrogen),
donkey anti-chicken-AF488 and donkey anti-mouse Cy5 (1/1000;
Jackson Inmuno Research, Baltimore Pike, PA). Finally, sections
were washed three times in 1 PBS and mounted in Vectashield
(Vector Laboratories, Burlingame, CA, USA). Images were
acquired using a Nikon C1 confocal microscope using the
EZ-C1 2.20 software and PlanApo objectives.
All mouse procedures followed the Guide for the Care and Use of
Laboratory Animals and were approved by the local institutional
animal care and use committee.
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